Cargando…

Viral Myocarditis—From Pathophysiology to Treatment

The diagnosis of acute and chronic myocarditis remains a challenge for clinicians. Characterization of this disease has been hampered by its diverse etiologies and heterogeneous clinical presentations. Most cases of myocarditis are caused by infectious agents. Despite successful research in the last...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schultheiss, Heinz-Peter, Baumeier, Christian, Aleshcheva, Ganna, Bock, C.-Thomas, Escher, Felicitas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623269/ https://www.ncbi.nlm.nih.gov/pubmed/34830522 http://dx.doi.org/10.3390/jcm10225240

Ejemplares similares

Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches
por: Baumeier, Christian, et al.
Publicado: (2023)

Interferon-β Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2022)

MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy
por: Aleshcheva, Ganna, et al.
Publicado: (2023)

Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy
por: Baumeier, Christian, et al.
Publicado: (2021)

Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2021)

Detection of viral SARS‐CoV‐2 genomes and histopathological changes in endomyocardial biopsies
por: Escher, Felicitas, et al.
Publicado: (2020)

MicroRNA profiling as a novel diagnostic tool for identification of patients with inflammatory and/or virally induced cardiomyopathies
por: Aleshcheva, Ganna, et al.
Publicado: (2020)

Proof of SARS-CoV-2 genomes in endomyocardial biopsy with latency after acute infection
por: Pietsch, Heiko, et al.
Publicado: (2021)

Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure
por: Pietsch, Heiko, et al.
Publicado: (2020)

Transcriptional Active Parvovirus B19 Infection Predicts Adverse Long-Term Outcome in Patients with Non-Ischemic Cardiomyopathy
por: Escher, Felicitas, et al.
Publicado: (2021)

Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series
por: Baumeier, Christian, et al.
Publicado: (2022)

New Echocardiographic Findings Correlate with Intramyocardial Inflammation in Endomyocardial Biopsies of Patients with Acute Myocarditis and Inflammatory Cardiomyopathy
por: Escher, Felicitas, et al.
Publicado: (2013)

FOXO3A acts as immune response modulator in human virus-negative inflammatory cardiomyopathy
por: Makrutzki-Zlotek, Kamila, et al.
Publicado: (2023)

Evaluation of Myocardial Gene Expression Profiling for Superior Diagnosis of Idiopathic Giant-Cell Myocarditis and Clinical Feasibility in a Large Cohort of Patients with Acute Cardiac Decompensation
por: Escher, Felicitas, et al.
Publicado: (2020)

Human myocardial mitochondrial oxidative capacity is impaired in mild acute heart transplant rejection
por: Scheiber, Daniel, et al.
Publicado: (2021)

Immunosuppressive treatment in fulminant myocarditis and gene expression pattern associated with, but no histological confirmation of giant cell myocarditis
por: Fruhwald, Friedrich, et al.
Publicado: (2017)

Pathophysiological Mechanisms of Cardiac Dysfunction in Transgenic Mice with Viral Myocarditis
por: Rohrbeck, Matthias, et al.
Publicado: (2023)

Cardiac Function Remains Impaired Despite Reversible Cardiac Remodeling after Acute Experimental Viral Myocarditis
por: Becher, Peter Moritz, et al.
Publicado: (2017)

Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis
por: Jiménez-Alejandre, Rosa, et al.
Publicado: (2022)

Acute viral myocarditis
por: Dennert, Robert, et al.
Publicado: (2008)

Understanding COVID-19-related myocarditis: pathophysiology, diagnosis, and treatment strategies
por: Shu, Hongyang, et al.
Publicado: (2023)

Familial Recurrent Myocarditis Triggered by Exercise in Patients With a Truncating Variant of the Desmoplakin Gene
por: Poller, Wolfgang, et al.
Publicado: (2020)

Multimodality Imaging Reveals Divergent Responses of Left and Right Heart to Treatment in Cardiac Amyloidosis
por: Poller, Wolfgang, et al.
Publicado: (2019)

Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis
por: Tschöpe, Carsten, et al.
Publicado: (2020)

Comparison of COVID-19 Vaccine-Associated Myocarditis and Viral Myocarditis Pathology
por: Hamedi, Kamron Reza, et al.
Publicado: (2023)

Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy
por: Siegismund, Christine S., et al.
Publicado: (2016)

Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
por: Palaskas, Nicolas, et al.
Publicado: (2020)

Reversible transition from a hypertrophic to a dilated cardiomyopathy
por: Spillmann, Frank, et al.
Publicado: (2015)

CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5
por: Lassner, Dirk, et al.
Publicado: (2018)

Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment
por: Gu, Xiaoying, et al.
Publicado: (2020)

COVID-19-Induced Myocarditis: Pathophysiological Roles of ACE2 and Toll-like Receptors
por: Pannucci, Patrizia, et al.
Publicado: (2023)

Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management
por: Abdelnabi, Mahmoud, et al.
Publicado: (2020)

Non-invasive imaging in the diagnosis of acute viral myocarditis
por: Jeserich, Michael, et al.
Publicado: (2009)

Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir
por: Koenig, Tobias, et al.
Publicado: (2021)

Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?
por: Favere, Kasper, et al.
Publicado: (2021)

Roles of inflammasomes in viral myocarditis
por: Xu, Jingyu, et al.
Publicado: (2023)

Pathophysiology of viral-induced exacerbations of COPD
por: Alfredo, Potena, et al.
Publicado: (2007)

Return to work in heart failure patients with suspected viral myocarditis
por: Reibis, Rona, et al.
Publicado: (2017)

Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart
por: Bräuninger, Hanna, et al.
Publicado: (2021)

Case report of severe PCR-confirmed COVID-19 myocarditis in a European patient manifesting in mid January 2020
por: Hudowenz, Ole, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6vl1ra5oovh6qidr1rlfjfdvv2